iBreeze +

The iBreeze + features a detachable water tank that snaps onto the device body. It's small enough to maintain the portable form factor but effective enough to provide meaningful humidification during therapy. The tank detaches completely for filling and cleaning — no wrestling with integrated reservoirs.

For travel scenarios where humidification isn't needed (short flights, dry therapy preference), the iBreeze + operates perfectly without the tank attached, saving additional weight and bulk. This modular approach gives patients flexibility: humidified therapy at home or in hotels, dry therapy on planes or in remote settings. For DME providers, the detachable design also simplifies cleaning, maintenance, and replacement — the tank is a separate serviceable component rather than an integrated unit.

CPAP and APAP devices are FAA-approved for in-flight use and do not count toward carry-on luggage limits on virtually all commercial airlines. The iBreeze + at 680g easily meets size and weight requirements for in-cabin medical equipment.

Patients should carry their device prescription or letter of medical necessity when traveling, and airlines may request it at check-in. The built-in battery eliminates the need for seat power connections — a practical advantage on flights without functioning power outlets or on regional carriers with older aircraft configurations common in LATAM routes. For distributors, the airline compliance angle is a strong selling point that resonates with travel-oriented patient demographics.

Yes. The iBreeze + is available in both fixed CPAP and APAP (auto-adjusting) configurations. Both share the same 680g form factor, 12-hour battery, and detachable water tank design.

The APAP variant is particularly relevant for travel use. Patients who sleep fine at home on a fixed pressure often need auto-adjustment when traveling — altitude changes, different sleeping positions in unfamiliar beds, and jet-lag-related breathing pattern shifts can all alter optimal pressure requirements. The APAP version handles this automatically. For distributors, stocking APAP is the safer bet for a portable device, though some markets still prefer clinician-set fixed pressure for compliance documentation reasons.

Up to 12 hours on a single charge with the built-in battery, and Resvent offers an optional modular battery for extended use on long-haul flights or multi-night camping trips. At 680g, the iBreeze + is lighter than most smartphones with a case — it fits in a jacket pocket.

The 12-hour figure assumes typical CPAP pressures (8–12 cmH2O). Higher pressures drain faster; lower pressures extend runtime. For wholesale buyers positioning the iBreeze + as a travel device, the battery spec is the lead feature. Competing travel CPAPs from ResMed (AirMini) and Philips (DreamStation Go) don't include an integrated battery at all — patients must purchase separate battery packs. The iBreeze + eliminates that accessory cost and simplifies the travel kit.

Both. While the iBreeze + was designed for portability, its clinical performance matches full-size home CPAPs on every metric that matters: pressure accuracy, leak compensation, IPR comfort algorithms, and therapy data logging. The 12-hour battery and 680g weight are travel features, not limitations.

Distributors in LATAM are positioning the iBreeze + as a dual-use device — one machine that covers home therapy and travel, eliminating the need to purchase (and insure) two separate devices. This resonates particularly well with private DME channels and cash-pay patients who want premium portability without sacrificing therapy quality. For institutional buyers, the dual-use positioning reduces SKU complexity in inventory management.